Registry for Ambulant Therapy With RAS-Inhibitors in Hypertension-patients in Germany

NCT01454583 · clinicaltrials.gov ↗

COMPLETED

Status

15337

Enrollment

OTHER

Sponsor class

Conditions

Arterial Hypertension

Interventions

DRUG: Aliskiren
DRUG: ACE-I/ARB
DRUG: No RAS-inhibition

Sponsor

Stiftung Institut fuer Herzinfarktforschung

Collaborators

[object Object]